These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 533399)

  • 41. Temporary liver support using a new type of sorbent. A urethane sheet embedded with powdered charcoal.
    Kawanishi H; Tsuchiya T; Hirabayashi A
    ASAIO Trans; 1988; 34(3):250-4. PubMed ID: 3196515
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Hemoperfusion adsorption and supporting from artificial liver].
    Duan ZP
    Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):503. PubMed ID: 12939191
    [No Abstract]   [Full Text] [Related]  

  • 43. The hepatix extracorporeal liver assist device in the treatment of fulminant hepatic failure.
    Kelly JH; Sussman NL
    ASAIO J; 1994; 40(1):83-5. PubMed ID: 7514459
    [No Abstract]   [Full Text] [Related]  

  • 44. Polydopamine/polyethyleneimine complex adhered to micrometer-sized magnetic carbon fibers for high-efficiency hemoperfusion.
    Liu RL; Wang Y; Ge XL; Yu P; Liu HQ; Wang MC; Lu W; Fu Q
    J Biomater Sci Polym Ed; 2017 Oct; 28(14):1444-1468. PubMed ID: 28498064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biocompatibility of different hemodialysis and plasmapheresis membranes.
    Jørstad S
    Blood Purif; 1987; 5(2-3):123-37. PubMed ID: 3497645
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The effect of hemoperfusion through activated charcoal on middle molecular substances in the plasma during a long-term dialysis program].
    Mydlík M; Dzúrik R; Derzsiová K; Spustová V
    Cas Lek Cesk; 1983 Dec; 122(51):1573-6. PubMed ID: 6652672
    [No Abstract]   [Full Text] [Related]  

  • 47. Acute liver failure.
    Silk DB; Williams R
    Br J Hosp Med; 1979 Nov; 22(5):437, 440-1, 445-6. PubMed ID: 540198
    [No Abstract]   [Full Text] [Related]  

  • 48. [A comparison of the efficiency of eliminating middle-weight molecules and myoinositol from plasma during hemoperfusion and hemodialysis in cases of chronic uremia].
    Trznadel K; Kidawa Z; Walasek L; Lutz W
    Pol Tyg Lek; 1978 Feb; 33(7):257-9. PubMed ID: 758030
    [No Abstract]   [Full Text] [Related]  

  • 49. Perspectives on the hemoperfusion of drugs and toxins.
    Schreiner GE
    Biomater Artif Cells Artif Organs; 1987; 15(1):305-21. PubMed ID: 3449146
    [No Abstract]   [Full Text] [Related]  

  • 50. Adsorption techniques: dialysis sorbents and membranes.
    Perego AF
    Blood Purif; 2013; 35 Suppl 2():48-51. PubMed ID: 23676836
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Artificial liver support systems.
    George J
    J Assoc Physicians India; 2004 Sep; 52():719-22. PubMed ID: 15839451
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Removal of endogenous middle molecules by hemoperfusion.
    Asaba H; Bergström J; Fürst P; Gunnarsson B; Neuhauser M; Oulès R; Yahiel V
    Artif Organs; 1979 May; 3(2):132-6. PubMed ID: 533396
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Current status and problems of artificial organs. 2. Artificial liver].
    Ohshima N; Kasai S; Mito M; Hori M
    Iyodenshi To Seitai Kogaku; 1983 Sep; 21(5):352-8. PubMed ID: 6376878
    [No Abstract]   [Full Text] [Related]  

  • 54. [Current status and future perspectives of extracorporeal blood purification].
    Falkenhagen D; Ahrenholz P; Klinkmann H
    Z Gesamte Inn Med; 1986 May; 41(10):297-305. PubMed ID: 3751193
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Albumin Apheresis for Artificial Liver Support: In Vitro Testing of a Novel Filter.
    Piatek T; Giebultowicz J; Rüth M; Lemke HD; Bonn F; Wroczynski P; Hrenczuk M; Malkowski P; Rozga J
    Ther Apher Dial; 2018 Aug; 22(4):399-409. PubMed ID: 29768707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Theoretical aspects of carbon adsorbent applications for detoxification.
    Nikolaev VG; Makhorin KE; Sergeev VP
    Biomater Artif Cells Artif Organs; 1987; 15(1):59-77. PubMed ID: 3449148
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Potentials of purification methods for the treatment of acute hepatic coma].
    Simeonov P
    Vutr Boles; 1981; 20(5):1-6. PubMed ID: 7034373
    [No Abstract]   [Full Text] [Related]  

  • 58. Chronic ambulatory liver support by membrane plasmapheresis with on-line detoxification.
    Asanuma Y; Malchesky P; Smith J; Zawicki I; Werynski A; Carey W; Ferguson D; Hermann R; Kayashima K; Nosé Y
    Trans Am Soc Artif Intern Organs; 1981; 27():416-22. PubMed ID: 7331105
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Neurologic improvement of patients with hepatic failure and coma during sorbent suspension dialysis.
    Ash SR; Blake DE; Carr DJ; Carter C; Howard T; Makowka L
    ASAIO Trans; 1991; 37(3):M332-4. PubMed ID: 1751174
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro adsorption of possible aetiological factors of hepatic encephalopathy.
    Chamuleau RA; Schoemaker LP; Smit EM
    Int J Artif Organs; 1979 Nov; 2(6):284-8. PubMed ID: 389835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.